Evofem Biosciences Reports Fourth Quarter and Year-End 2018 Financial Results and Provides Corporate Update

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 6/23/2026

1. SPCX
2. NVDA
3. ACN
4. MU
5. APGE
6. USO
7. GOOGL
8. HOOD
9. ABBV
10. DFTX

Go back to Evofem Biosciences Reports Fourth Quarter and Year-End 2018 Financial Results and Provides Corporate Update

Evofem Biosciences (EVFM) Misses Q4 EPS by 17c

March 1, 2019 6:06 AM EST

Evofem Biosciences (NASDAQ: EVFM) reported Q4 EPS of ($0.58), $0.17 worse than the analyst estimate of ($0.41).

"We are very pleased with the promising results from the AMPOWER trial, which met the agreed-upon primary endpoint," said Saundra Pelletier, Chief Executive Officer of Evofem. "The time is... More